Correlation Between Aridis Pharmaceuticals and Kymera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Kymera Therapeutics, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Kymera Therapeutics.

Diversification Opportunities for Aridis Pharmaceuticals and Kymera Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aridis and Kymera is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Kymera Therapeutics go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and Kymera Therapeutics

If you would invest  4,089  in Kymera Therapeutics on November 2, 2024 and sell it today you would lose (44.00) from holding Kymera Therapeutics or give up 1.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy5.26%
ValuesDaily Returns

Aridis Pharmaceuticals  vs.  Kymera Therapeutics

 Performance 
       Timeline  
Aridis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Kymera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Aridis Pharmaceuticals and Kymera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aridis Pharmaceuticals and Kymera Therapeutics

The main advantage of trading using opposite Aridis Pharmaceuticals and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.
The idea behind Aridis Pharmaceuticals and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.